Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hormone shot aims to boost power of diabetes cell transplant

NCT ID NCT03746769

Summary

This study is testing whether adding injections of a gut hormone called gastrin can help a smaller number of transplanted insulin-making cells work better in people with hard-to-manage type 1 diabetes. Participants will receive a single transplant of donor islet cells along with two rounds of daily gastrin injections, while also taking lifelong anti-rejection medications. The goal is to see if this combination is safe and can help patients become insulin-independent with stable blood sugar.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

    Contact

Conditions

Explore the condition pages connected to this study.